Skip to main content
2026 AAOMS 108th Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed <br><i>This session/event requires a ticket.</i>
Ticketed
This session/event requires a ticket.
In-person only<br><i>This session is offered in-person only.</i>
In-person only
This session is offered in-person only.
On-demand<br><i>On-demand session available beginning Sept. 28.</i>
On-demand
On-demand session available beginning Sept. 28.
Recorded<br><i>This session will be recorded and available beginning Oct. 19</i>
Recorded
This session will be recorded and available beginning Oct. 19
Sold Out<br><i>This ticketed session/event is sold out.</i>
Sold Out
This ticketed session/event is sold out.

Head and Neck

OMS and Other Dental Specialists

Session: Current Concepts and Controversies in Head and Neck Surgery and Reconstruction

XHN - The Role of Neoadjuvant Immunotherapy in Advanced Resectable Oral/Head and Neck Cancer

Wednesday, September 30, 2026
8:25 AM - 9:10 AM PDT
Location: Room 320-322, Seattle Convention Center Summit

    Speaker(s)

  • Dan P. Zandberg, MD

    Professor of Medicine Tom W. Olofson Chair in Head and Neck Cancer Research Associate Director for Clinical Research, UPMC Hillman Cancer Center Co-Leader of the UPMC Hillman Head and Neck Cancer Program
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania

The COHNORS Preconference will bring together experts in the field of oral/head and neck oncology to share recent groundbreaking developments as well as explore controversial topics in benign and malignant disease of the oral/head and neck region. The preconference also will serve as a format to foster the ongoing collaboration necessary for success of AAOMS members practicing in this subspeciality area.

Learning Objectives:

At the conclusion of this presentation, participants should be able to:
  1. Discuss the role of adjuvant immunotherapy in the treatment of advanced resectable oral/head and neck cancer.
  2. Identify necessary concepts for application of immunotherapy strategies in the overall treatment of oral/head and neck cancer.
  3. Understand algorithms described in the AAOMS Position Paper for decision-making in the treatment of the N0 neck in oral/head and neck cancer patients.